Peer-Review Report of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9353)
All Articles published online
|
Publishing Process of This Article
|
Jan 15, 2022 (publication date) through Apr 7, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Luo Y, Teng F, Fu H, Ding GS. Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons. World J Gastrointest Oncol 2022; 14(1): 163-180 [PMID: 35116109 DOI: 10.4251/wjgo.v14.i1.163] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Luo Y, Teng F, Fu H, Ding GS. Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons. World J Gastrointest Oncol 2022; 14(1): 163-180 [PMID: 35116109 DOI: 10.4251/wjgo.v14.i1.163] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i1/163.htm |
| Number | Citing Articles |
| 1 |
Arno Kornberg, Linda Kaschny, Jennifer Kornberg, Helmut Friess. Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation. Journal of Hepatocellular Carcinoma 2022; : 649 doi: 10.2147/JHC.S366107
|
| 2 |
Zurabi Lominadze, Kareen Hill, Mohammed Rifat Shaik, Justin P. Canakis, Mohammad Bourmaf, Cyrus Adams-Mardi, Ameer Abutaleb, Lopa Mishra, Kirti Shetty. Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review. International Journal of Molecular Sciences 2023; 24(3): 2358 doi: 10.3390/ijms24032358
|
| 3 |
Elisa Fuochi, Lorenzo Anastasio, Erica Nicola Lynch, Claudia Campani, Gabriele Dragoni, Stefano Milani, Andrea Galli, Tommaso Innocenti. Main factors influencing long-term outcomes of liver transplantation in 2022. World Journal of Hepatology 2023; 15(3): 321-352 doi: 10.4254/wjh.v15.i3.321
|
| 4 |
Tian Song, Kan-Hua Wu, Hao Yang, Wen-Li Xie, Lan Shen. Multidisciplinary treatment strategies for the assessment of immune, coagulation, and biomarker responses after transarterial chemoembolization for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2025; 17(5): 101605 doi: 10.4240/wjgs.v17.i5.101605
|
| 5 |
Miho Akabane, Yuki Imaoka, Jun Kawashima, Austin Schenk, Timothy M. Pawlik. Immunotherapy in liver transplantation for hepatocellular carcinoma: A comprehensive review. Journal of Liver Transplantation 2025; 17: 100256 doi: 10.1016/j.liver.2024.100256
|
| 6 |
Luyu Li, Yaorui Hu, Xiao Li, Baojun Ju. A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review. Medicine 2024; 103(15): e37688 doi: 10.1097/MD.0000000000037688
|
| 7 |
Maneerat Chayanupatkul, Thomas D. Schiano. Hepatology. 2025; : 1261 doi: 10.1016/B978-0-443-26711-6.00043-3
|
| 8 |
Xiufeng Liu, Yinying Lu, Weiping Zhou, Tao Peng, Jie Zhou, Huaqiang Bi, Feng Xia, Xiaoping Chen. Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition). Liver Cancer 2024; 13(4): 355 doi: 10.1159/000535496
|
| 9 |
Dalal Alhaqqan, Yii Chun Khiew, Maryam Dadashzadeh, Aiwu Ruth He, Arul Thomas, Amol Rangnekar. Harnessing the Power of Immunotherapy in Liver Transplantation for HCC. Current Transplantation Reports 2024; 11(3): 131 doi: 10.1007/s40472-024-00439-3
|
| 10 |
Shaobo Zhang, Shugeng Zhang. Successful Liver Transplantation After Achieving Complete Clinical Remission of Hepatocellular Carcinoma With Combination Therapy of Immune Checkpoint Inhibitors and Targeted Agents: A Case Report. Transplantation Proceedings 2025; 57(4): 580 doi: 10.1016/j.transproceed.2025.02.041
|
| 11 |
Shabana Begum, Pranab Behari Mazumder, Anupam Das Talukdar. In vitro evaluation of anticancer activity of Oxalis corniculata L., by harnessing exosome for effective drug delivery against hepatocellular carcinoma. Pharmacological Research - Natural Products 2025; 8: 100298 doi: 10.1016/j.prenap.2025.100298
|
| 12 |
Carrie E. Ryan, Jacob Lambdin, Shimul Shah, Ralph Cutler Quillin, Kristina Lemon, Jonathan M. Hernandez, Davendra Sohal. Durvalumab and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant. Annals of Surgical Oncology 2023; 30(2): 686 doi: 10.1245/s10434-022-12811-7
|
| 13 |
Parissa Tabrizian, Marcus Zeitlhoefler, Ahmed Talaat Hassan, Rebecca Marino. Immunotherapy for transplantation of hepatocellular carcinoma: the next frontier in adjunctive therapy. Current Opinion in Organ Transplantation 2024; 29(2): 144 doi: 10.1097/MOT.0000000000001133
|
| 14 |
Miho Akabane, Odysseas Chatzipanagiotou, Yuki Imaoka, Austin Schenk, Timothy Pawlik. Advancing Adjuvant Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review. ImmunoTargets and Therapy 2025; : 631 doi: 10.2147/ITT.S528709
|
| 15 |
Francesca Salani, Virginia Genovesi, Caterina Vivaldi, Valentina Massa, Silvia Cesario, Laura Bernardini, Miriam Caccese, Jessica Graziani, Dario Berra, Lorenzo Fornaro, Gianluca Masi. Primary Resistance to Immunotherapy-Based Regimens in First Line Hepatocellular Carcinoma: Perspectives on Jumping the Hurdle. Cancers 2022; 14(19): 4896 doi: 10.3390/cancers14194896
|
| 16 |
Maciej Gryziak, Krzysztof Wozniak, Leszek Kraj, Letycja Rog, Rafal Stec. The immune landscape of hepatocellular carcinoma‑where we are? (Review). Oncology Letters 2022; 24(5) doi: 10.3892/ol.2022.13530
|
| 17 |
|
| 18 |
Anran Liu, Jiang Zhang, Tong Li, Danyang Zheng, Yihong Ling, Lianghe Lu, Yuanpeng Zhang, Jing Cai. Explainable attention-enhanced heuristic paradigm for multi-view prognostic risk score development in hepatocellular carcinoma. Hepatology International 2025; 19(4): 866 doi: 10.1007/s12072-025-10793-8
|
| 19 |
Kevin Tak-Pan Ng, Jiang Liu, Oscar Wai-Ho Yeung, Li Pang, Hoi Chung Shiu, Hui Liu, Xin Xiang Yang, Albert Chi-Yan Chan, Tiffany Cho-Lam Wong, Chung Mau Lo, Kwan Man. Post-transplant inflammatory cytokine signature adds value for predicting tumor recurrence after liver transplantation for hepatocellular carcinoma. Hepatology International 2023; 17(6): 1596 doi: 10.1007/s12072-023-10566-1
|
| 20 |
Wanyue Cao, Jing Lu, Shanbao Li, Fangbin Song, Junming Xu. Transcriptomic analysis of graft liver provides insight into the immune response of rat liver transplantation. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.947437
|
| 21 |
Francesca Romana Ponziani, Valerio Giannelli, Giuseppe Marrone, Silvia Martini, Maria Cristina Morelli, Duilio Pagano, Gianluca Svegliati Baroni, Giacomo Germani, Patrizia Burra, Pierluigi Toniutto, Leonardo Stella, Silvia Strona, Margherita Saracco, Francesco Fabrizio, Marco Giacchetto, Michele Montori. Expert Consensus on the Use of Immune Checkpoint Inhibitors in the Liver Transplant Setting: Guidance from the Liver Transplant Committee of the Italian Association for the Study of the Liver (AISF). American Journal of Transplantation 2026; doi: 10.1016/j.ajt.2026.02.024
|
| 22 |
Konstantinos Ouranos, Anthi Chatziioannou, Ioannis Goulis, Emmanouil Sinakos. Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation. World Journal of Transplantation 2022; 12(11): 331-346 doi: 10.5500/wjt.v12.i11.331
|
| 23 |
Mohammad Saeid Rezaee-Zavareh, Soo Young Hwang, Naomy Kim, Hasmik Adetyan, Nguyen H. Tran, Ju Dong Yang. Managing hepatocellular carcinoma recurrence after liver transplantation: emerging role of immune checkpoint inhibitors. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03226-3
|